Coston McIsaac & Partners’s Thermo Fisher Scientific TMO Stock Holding History

Coston McIsaac & Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42K	Hold	85	–	–	0.01%	364
2026 Q1	$42K	Hold	85	–	–	0.01%	349
2025 Q4	$49K	Sell	85 -7	-8%	-$3.96K	0.01%	320
2025 Q3	$44K	Hold	92	–	–	0.01%	332
2025 Q2	$37K	Hold	92	–	–	0.01%	345
2025 Q1	$45K	Hold	92	–	–	0.01%	288
2024 Q4	$48K	Hold	92	–	–	0.01%	280
2024 Q3	$57K	Hold	92	–	–	0.02%	259
2024 Q2	$51K	Hold	92	–	–	0.02%	260
2024 Q1	$53K	Hold	92	–	–	0.02%	259
2023 Q4	$48K	Buy	92 +16	+21%	+$7.75K	0.02%	260
2023 Q3	$38K	Sell	76 -5	-6%	-$2.66K	0.01%	283
2023 Q2	$42K	Hold	81	–	–	0.01%	300
2023 Q1	$46K	Buy	81 +1	+1%	+$564	0.02%	272
2022 Q4	$44K	Hold	80	–	–	0.02%	286
2022 Q3	$41K	Sell	80 -1	-1%	-$560	0.02%	242
2022 Q2	$44K	Buy	+81	New	+$44.6K	0.03%	144

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Coston McIsaac & Partners's TMO Position: Q2 2026 in Review

Coston McIsaac & Partners held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 85 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #364.

Coston McIsaac & Partners first reported a position in TMO in Q2 2022 and has held it in 17 quarters since. The position peaked at $57K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Coston McIsaac & Partners held 85 shares of Thermo Fisher Scientific worth $42K as of Q2 2026.
Coston McIsaac & Partners left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #364 holding.
Coston McIsaac & Partners first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Thermo Fisher Scientific position peaked at $57K in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.